Ionetix Corp / DE /

Ionetix Corp, incorporated in Delaware, filed an 8-K current report with the Securities and Exchange Commission on May 20, 2026, accession number 0001213900-26-059341. Ionetix operates in the radiopharmaceutical and nuclear medicine sector, developing compact medical cyclotron systems for the production of medical isotopes used in PET imaging diagnostics. The company carries SEC CIK 0002108121. As an 8-K filer of interest to SPAC researchers, material events disclosed in such current reports can signal transaction milestones, management changes, or other developments relevant to deal tracking. Visit SpacDesk and create a free account to access full filing details, sponsor data, and real-time alerts on Ionetix Corp and hundreds of other SPAC-linked entities.